Alle Personen

Prof. Erhard Seifried

Weitere Beteiligungen

  • –   
    • Abstractvortrag (Best Abstract)
    • VS-5-2 (Best Abstract)
    Using a mathematical simulation model to predict the impact of changes in platelet concentrate shelf life
     2. Versorgungsforschung, 5. Infektionssicherheit von Blutprodukten
  • –   
    • Abstractvortrag
    • VS-9-3
    Rapid and complete Clearance of HPA-1a mismatched Platelets in a human Model of Fetal and Neonatal Alloimmune Thrombocytopenia by a hyperimmune Plasma derived polyclonal HPA-1a antibody
     21. Fetomaternale Inkompatibilität, 7. Immunhämatologie und Immunologische Grundlagen
  • –   
    • Abstractvortrag
    • VS-13-3
    Long-term Follow up (> 1 year) of Plasma Donors and Patients treated with COVID-19 Convalescent Plasma within the CAPSID trial
     19. COVID-19, 9. Hämotherapie
  • –   
    • Abstractvortrag
    • VS-13-4
    A Randomised Open-Label Trial of Early, Very High-Titre Convalescent Plasma Therapy in Clinically Vulnerable Individuals with Mild COVID-19 as model of early treatment in a pandemia with a new pathogen: Experience from collection of very high-titer plasma from superimmunized individuals
     1. Blutspende und Donormanagement, 19. COVID-19
  • –   
    • Poster
    • PS-1-6
    Machine learning modelling to precisely predict hemoglobin and iron content in individual packed red blood cell units
     18. Zukunftsgebiete der Transfusionsmedizin, 3. Blutkomponenten – Herstellung und Qualitätskontrolle
  • –   
    • Poster
    • PS-2-12
    Development of a test cell-panel that provides the framework for fast, sensitive and reliable FNAIT-causing HPA antibody detection
     21. Fetomaternale Inkompatibilität, 7. Immunhämatologie und Immunologische Grundlagen
  • –   
    • Poster
    • PS-1-13
    Quality assessment of routine produced mirasol pathogen reduction system treated platelet concentrates
     18. Zukunftsgebiete der Transfusionsmedizin, 5. Infektionssicherheit von Blutprodukten
  • –   
    • Poster
    • PS-4-18
    Human breast milk bank – Frankfurt experience after > 3500 bottles of delivered donor human breast milk
     18. Zukunftsgebiete der Transfusionsmedizin, 3. Blutkomponenten – Herstellung und Qualitätskontrolle
  • © Conventus Congressmanagement & Marketing GmbH